ADVFN US – Market Content Editor
-
Freeport-McMoRan Shares Drop Following Fatal Mine Incident and Production Adjustments
Shares of Freeport-McMoRan Inc. (NYSE:FCX) tumbled 7% in pre-market trading Wednesday after the company confirmed that two workers were found dead at its Grasberg Block Cave mine in Indonesia, with five others still unaccounted for following a severe mud rush. The copper and gold mining giant reported that on September 20, two employees were discovered…
-
Terra Innovatum Accelerates NRC Licensing Path for SOLO™ Micro-Modular Reactor
Terra Innovatum Srl, a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (NASDAQ:GSRT) announced accelerated progress in the U.S. Nuclear Regulatory Commission (NRC) licensing process for its SOLO™ reactor, marking key milestones in 2025 aimed at streamlining commercial deployment. Since the start of the year, Terra Innovatum has submitted several critical regulatory documents…
-
Dow Jones, S&P, Nasdaq, Futures, Wall Street May See Early Upside as AI Optimism Persists
U.S. stock futures point to a modestly higher open on Wednesday, suggesting that equities could rebound after yesterday’s broad sell-off. Investor confidence in the AI sector remains strong, continuing to drive market gains and record highs. Shares of Nvidia (NASDAQ:NVDA) are showing early gains, rising 0.4% in pre-market trading after falling 2.8% on Tuesday. The…
-
Acadia Healthcare Shares Jump on Activist Investor Stake Report
Shares of Acadia Healthcare Company (NASDAQ:ACHC) rose 5% on Wednesday after the Financial Times reported that activist investor Engine Capital has acquired a stake in the mental health services provider. The report indicates that Engine Capital now holds roughly 3% of Acadia’s shares and is advocating for major corporate changes amid ongoing federal investigations. In…
-
Acadia Pharmaceuticals Shares Drop After Phase 3 PWS Trial Misses Primary Goal
Shares of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) fell 13% on Wednesday following the announcement that its Phase 3 COMPASS trial for Prader-Willi syndrome (PWS) did not meet the primary endpoint. The study tested intranasal carbetocin (ACP-101) for hyperphagia in PWS patients. The trial did not show a statistically significant improvement over placebo on the Hyperphagia Questionnaire…
-
Uranium Energy Posts Lower-Than-Expected Fiscal Revenue, Shares Tick Up
Uranium Energy Corp (AMEX:UEC) reported fiscal 2025 revenue of $66.84 million on Wednesday, falling short of analyst expectations of $77.2 million, while registering a loss of -$0.20 per share versus the consensus estimate of -$0.18. Despite the revenue miss, the company’s shares rose 1.66% in pre-market trading. The producer sold 810,000 pounds of uranium in…
-
Rivian Delivery Vans Face Preliminary NHTSA Review Over Seat Belt Concerns
The U.S. National Highway Traffic Safety Administration (NHTSA) has launched an initial review of 17,198 Rivian (NASDAQ:RIVN) electric delivery vans amid questions about the performance of their seat belts. The agency announced the investigation on Wednesday, targeting the seat belt systems in these commercial electric vehicles. The evaluation will assess potential safety issues regarding how…
-
Thor Industries Beats Q4 Expectations, Braces for “Another Challenging Year”
Thor Industries, Inc. (NYSE:THO) posted fourth-quarter results that exceeded analyst projections, with shares up 0.7% in premarket trading following the announcement. The recreational vehicle manufacturer reported adjusted earnings per share of $2.36 for the quarter ending July 31, 2025, surpassing the consensus estimate of $1.25 by $1.11. Revenue totaled $2.52 billion, above analysts’ expectations of…
-
Lithium Americas Shares Surge 58% Amid Reports of U.S. Government Equity Interest
Shares of Lithium Americas Corp (NYSE:LAC) soared 58% on Wednesday after news surfaced that the U.S. government is exploring taking an equity stake in the lithium producer. The sharp rise in the stock price follows reports that federal officials are renegotiating the terms of a previously announced $2.3 billion loan. The original loan, aimed at…
-
James Hardie Shares Slip 3.2% in U.S. on Incentives, Target Discrepancies
James Hardie (NYSE:JHX) shares fell 3.2% in U.S. trading after the company released its figures on material incentives and targets, which appear to diverge noticeably from market expectations, according to Citi. The building materials manufacturer’s reported numbers showed a clear departure from what analysts had projected, though Citi did not provide further details on the…